TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas
Kun Wang(Hebei Medical University), Dawei Xu(Karolinska University Hospital), Chang Wang(Hebei Medical University), Tiantian Liu(Karolinska University Hospital), Cheng Liu(Scripps Research Institute), Nan Ge(Second Hospital of Shandong University), Keqiang Yan(Qilu Hospital of Shandong University), Jikai Liu(Qilu Hospital of Shandong University), Yidong Fan(Qilu Hospital of Shandong University), Hongbo Ren(Qilu Hospital of Shandong University), Sanyuan Hu(Shandong University), Li Liu(The First Affiliated Hospital, Sun Yat-sen University), Magnus Björkholm(Karolinska University Hospital)
Cited by 86
Related Papers
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Lipids and Lipid Derivatives for RNA Delivery
|Chemical Reviews|2021|592
Large-Area, Flexible, Transparent, and Long-Lived Polymer-Based Phosphorescence Films
|Journal of the American Chemical Society|2021|513
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players
|Oncogene|2019|465
ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer
|Journal of Experimental & Clinical Cancer Research|2022|433